Veradigm | MDRX - Passivo Circulante





Passivo Circulante Alterar Data
Alcidion AUD 22.33M 1.47M 2025-12
Ambu A/S DKK 1.03B 33M 2026-03
Amplifon EUR 1.59B 334.22M 2026-03
Cardinal Health USD 41.99B 1.33B 2026-03
Centene USD 40.04B 3.35B 2026-03
Charles River Laboratories USD 1.09B 26.61M 2026-03
Cigna USD 52.61B 3.74B 2026-03
Coloplast 7.93B 1.42B 2025-12
Computer Programs Systems USD 57.96M 4.21M 2025-12
Convatec Group USD 512.3M 130.7M 2024-12
CVS Health USD 86.41B 2.29B 2026-03
Diasorin EUR 555.45M 289.08M 2025-06
Elevance Health USD 45.31B 4.27B 2026-03
General Electric Aerospace USD 40.03B 1.05B 2026-03
Gulf Medical Proj AED 171.09M 18.53M 2025-12
Humana USD 21.51B 5.16B 2026-03
IQVIA Holdings USD 8.33B 9M 2026-03
Laboratory Of America USD 2.64B 182.5M 2026-03
Maximus USD 681.69M 73.64M 2026-03
McKesson USD 67.02B 1.11B 2026-03
Med Life RON 883.35M 20.56M 2025-12
Molina Healthcare USD 8.19B 816M 2026-03
Omnicell USD 483.05M 6.44M 2026-03
Oriola-kd EUR 649.7M 140.4M 2026-03
Owens Minor USD 1.2B 256.03M 2026-03
Quest Diagnostics USD 2.18B 101M 2026-03
Rede D'or Sao Luiz BRL 19.13B 146.56M 2026-03
Siemens Healthineers EUR 12.89B 767M 2026-03
Sonova Holding CHF 1.5B 303M 2025-06
Supermax Corporation Bhd MYR 335.77M 15.65M 2026-03
UnitedHealth USD 114.12B 773M 2026-03
Veeva Systems USD 1.7B 64.71M 2026-03
Veradigm USD 230.31M 22.78M 2022-12
Xerox USD 3.2B 20M 2026-03